(Reuters) - U.S. COVID vaccine manufacturers set list prices for their shots between $120 and $130 per dose, company executives said at an advisory panel meeting of U.S. Centers for Disease Control and Prevention on Tuesday.
Pfizer (NYSE:PFE) and German partner BioNTech set the list price at $120 per dose, while Moderna (NASDAQ:MRNA) said the list price for its shot is $129 per dose, for their respective COVID vaccines.
Novavax (NASDAQ:NVAX) said the list price for its COVID vaccine was $130 per dose.